At baseline, a total of 182 consecutive participants with HT and 182 age- and sex-matched ischemic stroke patients without HT were enrolled in this study, among whom 345 (94.8%) patients had information on all the lymphocyte count, total cholesterol, and albumin data. This evidence concerns the gene ALB and ischemic stroke.